A human mybpc3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death

HIGHLIGHTS

• who: Equal contributors and colleagues from the Laboratoire cardiogénétique, Centre de Biologie et Pathologie Est, Groupe Hospitalier Est, boulevard Pinel, Bron, Lyon, France have published the research work: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death, in the Journal: (JOURNAL)
• what: The informed consent was requested for diagnosis and for research purposes. Despite the late onset and the delayed evolution towards complications, the study shows that cardiologists should keep in mind a risk of SD . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.